Medicortex

Medicortex is a biotechnology company dedicated to improving the diagnosis, treatment, and prevention of acute neurodegenerative diseases, including enhancing the diagnosis and treatment of traumatic brain injury (TBI). One of the company's missions is to identify a new biomarker that can reliably assess the severity of brain injury. The current focus is on developing a diagnostic kit for detecting traumatic brain injury (TBI), and the next goal will be to develop an innovative drug to halt the progression of initial brain injury.